Schizophrenia following new-onset refractory status epilepticus secondary to antiphospholipid syndrome

References

1. ↵
   1. Hilger E,
   2. Zimprich F,
   3. Pataraia E,
   4. Aull-Watschinger S,
   5. Jung R,
   6. Baumgartner C,
   7. et al.

   (2016) Psychoses in epilepsy:A comparison of postictal and interictal psychoses. Epilepsy Behav 60, 58–62.
2. ↵
   1. Meletti S,
   2. Giovannini G,
   3. d'Orsi G,
   4. Toran L,
   5. Monti G,
   6. Guha R,
   7. et al.

   (2017) New-Onset Refractory Status Epilepticus with Claustrum Damage:Definition of the Clinical and Neuroimaging Features. Front Neurol 8, 111.
3. ↵
   1. Regina P,
   2. Pnina R,
   3. Natur A,
   4. Yair L

   (2017) Anti-phospholipid syndrome associated with schizophrenia description of five patients and review of the literature. Immunol Res 65, 438–446.
4. ↵
   1. Muscal E,
   2. Brey R

   (2008) Neurologic manifestations of the antiphospholipid syndrome:Integrating molecular and clinical lessons. Curr Rheumatol Rep 10, 67–73.
5. ↵
   1. Kirmani B,
   2. Barr D,
   3. Robinson D,
   4. Pranske Z,
   5. Fonkem E,
   6. Benge J,
   7. et al.

   (2018) Management of Autoimmune Status Epilepticus. Front Neurol 9, 259.
6. ↵
   1. Hoirisch-Clapauch S,
   2. Amaral O,
   3. Mezzasalma M,
   4. Panizzutti R,
   5. Nardi A

   (2016) Dysfunction in the coagulation system and schizophrenia. Transl Psychiatry 6, 704.
7. ↵
   1. Graf J

   (2017) Central Nervous System Manifestations of Antiphospholipid Syndrome. Rheum Dis Clin North Am 43, 547–560.
8. ↵
   1. Cascella N,
   2. Schretlen D,
   3. Sawa A

   (2009) Schizophrenia and epilepsy:is there a shared susceptibility? Neurosci Res 63, 227–235.
9. ↵
   1. Dedeurwaerdere S,
   2. Boets S,
   3. Janssens P,
   4. Lavreysen H,
   5. Steckler T

   (2015) In the grey zone between epilepsy and schizophrenia:alterations in group II metabotropic glutamate receptors. Acta Neurol Belg 115, 221–232.
10. ↵
    1. Vonberg F,
    2. Bigdeli T

    (2016) Genetic Correlation Between Schizophrenia and Epilepsy. JAMA Neurol 73, 125–126.